×
Stock Screener
Stock Research
Top Dividend Stocks
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Omega Therapeutics Financial Statements 2020-2023 | OMGA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Income Statement
Balance Sheet
Cash Flow Statement
Key Financial Ratios
Format: Annual
Format: Quarterly
Format: Annual
View Annual Reports
Loading...
Annual Data | Millions of US $ except per share data
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Revenue
$3.094
$2.073
$0.144
-
Cost Of Goods Sold
-
-
-
-
Gross Profit
$3.094
$2.073
$0.144
-
Research And Development Expenses
$77.169
$81.167
$47.865
$21.063
SG&A Expenses
$26.186
$23.672
$16.603
$6.236
Other Operating Income Or Expenses
-
-
$-1.708
$-1.346
Operating Expenses
-
-
-
-
Operating Income
$-100.261
$-102.766
$-66.032
$-28.645
Total Non-Operating Income/Expense
$2.833
$0.065
$-2.248
$-0.802
Pre-Tax Income
$-97.428
$-102.701
$-68.28
$-29.447
Income Taxes
-
-
-
-
Income After Taxes
$-97.428
$-102.701
$-68.28
$-29.447
Other Income
-
-
-
-
Income From Continuous Operations
$-97.428
$-102.701
$-68.28
$-29.447
Income From Discontinued Operations
-
-
-
-
Net Income
$-97.428
$-102.701
$-68.28
$-29.447
EBITDA
$-93.437
$-97.509
$-64.552
$-27.451
EBIT
$-100.261
$-102.766
$-66.032
$-28.645
Basic Shares Outstanding
54
48
22
4
Shares Outstanding
54
48
22
4
Basic EPS
$-1.80
$-2.14
$-3.05
$-7.54
EPS - Earnings Per Share
$-1.80
$-2.14
$-3.05
$-7.54
www.jqwidgets.com